Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

February 5, 2015

Primary Completion Date

January 20, 2017

Study Completion Date

February 17, 2017

Conditions
Hypertrophic Cardiomyopathy
Interventions
DRUG

Eleclazine

Tablet (s) administered orally once daily

DRUG

Placebo

Placebo to match eleclazine administered orally once daily

Trial Locations (46)

Unknown

Cedars-Sinai Heart Institute, Los Angeles

University of California Los Angeles, Los Angeles

Stanford University, Stanford

Yale New Haven Hospital, New Haven

Athens Regional Medical Center, Athens

Northwestern Memorial Hospital, Chicago

University of Iowa Hospitals and Clinics, Iowa City

Brigham & Women's Hospital and Harvard Medical School, Boston

Massachusetts General Hospital, Boston

Tufts Medical Center, Boston

Washington University School of Medicine, St Louis

Morristown Medical Center, Morristown

Columbia University Medical Center/ New York Presbyterian, New York

NYU School of Medicine Pediatrics, New York

Duke Health Center at Southpoint, Durham

Oregon Health and Science University, Portland

St. Luke's University Health Network, Bethlehem

University of Pittsburgh Medical Center, Pittsburgh

St. Thomas Research Institute, Nashville

Vanderbilt University Medical Center, Nashville

Houston Methodist Hospital, Houston

Texas Heart Institute, Houston

UT Southwestern Medical Center, Houston

University of Washington, Seattle

Marshfield Clinic Research Institute, Marshfield

Medical College of Wisconsin, Milwaukee

The Alfred Hospital, Melbourne

Hôpital Européen Georges Pompidou, Paris

Universitätsklinikum Hamburg Eppendorf, Hamburg

Ein Kerem-Hadassah Medical Organization, Jerusalem

Rabin Medical Center, Petah Tikva

Sheba Medical Center, Ramat Gan

Tel Aviv Sourasky Medical Center, Tel Aviv

Madonna del Soccorso Hospital, San Benedetto del Tronto

Azienda Ospedaliera Papa Giovanni XXIII, Bergamo

Azienda Ospedaliero Universitaria Di Bologna, Bologna

Azienda Ospedaliera Universitaria Careggi, Florence

Ospedale San Raffaele S.r.l., Milan

Azienda Ospedaliera Monaldi, Naples

Azienda Ospedaliero Universitaria di Parma, Parma

Azienda Ospedaliera San Camillo Forlanini, Rome

Academisch Medisch Centrum Amsterdam, Amsterdam

Erasmus MC, Rotterdam

University Medical Center Utrecht, Utrecht

University Hospital of Wales, Cardiff

Northern General Hospital, Sheffield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY